Late injury of cancer therapy on the female reproductive tract

International Journal of Radiation Oncology, Biology, Physics

Volumn 31, Issue 5, 1995, Pages 1281-1299

  Grigsby, Perry W ^a   Russell, Anthony ^b   Bruner, Deborah ^c   Eifel, Patricia ^d   Koh, Wui Jin ^e   Spanos, William ^f   Stetz, Joann ^g   Stitt, Judith Anne ^h   Sullivan, Jessie ⁱ  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Radiological Associates of Sacramento Medical Group Inc   (United States)

^c FOX CHASE CANCER CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF LOUISVILLE   (United States)

^g RTOG Headquarters   (United States)

^h UNIVERSITY OF WISCONSIN MADISON   (United States)

ⁱ NEW YORK UNIVERSITY   (United States)

Author keywords

Cervix; Chemotherapy; Fallopian tube; Female reproductive tract; Late effects; Ovary; Radiation; Surgery; Uterus; Vagina; Vulva

Indexed keywords

CANCER RADIOTHERAPY; CONFERENCE PAPER; DOSE RESPONSE; FEMALE; FEMALE GENITAL SYSTEM; HUMAN; OVARY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; UTERINE CERVIX; UTERINE TUBE; UTERUS; VAGINA; VULVA;

DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENITALIA, FEMALE; HUMAN; OVARY; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY; SEX DISORDERS; UTERUS; VAGINA; VULVA;

EID: 0028946698     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(94)00426-L     Document Type: Article

References (61)

1. Fluid detection in the uterus during and after irradiation for carcinoma of the cervix: Clinical implications
2. The irradiated vagina
3. Sexual dysfunction after therapy for cervical carcinoma
4. Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease
5. A new tehnique for ovarian transposition
6. Comments on the development of amenorrhea caused by myleran in cases of chronic myelosis
7. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva
8. Vaginal stenosis and sexual function following intracavitary radiation for the treatment of cervical and endometrial carcinoma
9. Sexual rehabilitation of the gynecologic cancer patient: An effective counseling model
10. Sequelae of lateral ovarian transposition in unirradiated cervical cancer patients
11. Cytotoxic therapy on sexuality and gonadal function
12. Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease
13. Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function
14. Estrogen excretion in breast cancer patients before and after ovarian irradiation and oophorectomy
15. Tolerance of normal tissue to therapeutic irradiation
16. Female reproductive organs
17. Malignancy of the uterine corpus following irradiation therapy for squamous cell carcinoma of the cervix
18. L-phenylalanine mustard (L-PAM) in the managment of premenopausal patients with primary breast cancer: Lack of association of disease-free survial with depression of ovarian function. National Surgical Adjuvant Project for Breast and Bowel Cancers
19. Preliminary report Long-term cyclophosphamide therapy in rheumatoid arthritis
20. The measurement of sexual dysfunction in cancer patients
21. Medically inoperable stage I adenocarcinoma of the endometrium treated with radiotherapy alone
22. The incidence of persistent functioning endometrial tissue following successful radiotherapy for cervical carcinoma
23. Radiation tolerance of the vaginal mucosa
24. The role of ovarian transposition in conservation of ovarian function in radical hysterectomy followed by pelvic radiation
25. The preservation of ovarian function in young women undergoing pelvic radiation therapy
26. The treatment of female sterility with x-ray therapy directed to the pituitary and ovaries
27. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer
28. Psychological adjustment of women to gynecologic cancers
29. Adenocarcinoma of the uterine corpus following irradiation for cervical cancer
30. Sexual adjustment after radiation therapy for cervical carcinoma
31. Pregnancy following oophoropexy and total nodal irradiation in women with Hodgkin's disease
32. A new technique to protect ovarian function before pelvic irradiation: Heterotopic ovarian autotransplantation
33. Ovarian ablation failures by radiation
34. Quality of life in patients with gynecologic cancer
35. Persisting cyclical uterine bleeding in patients treated with radical radiation therapy and hormonal replacement for carcinoma of the cervix
36. Multiple late complications of therapy with cyclophosphamide, including ovarian destruction
37. Ovarian lesions due to cytostatic agents during the treatment of Hodgkin's disease
38. Hormonal studies in artificial menopause produced by roentgen rays
39. Chemotherapeutic toxicities: A comprehensive overview
40. The treatment of female infertility by x-ray therapy
41. Castration of the female by irradiation The results in 334 patients
42. Definitive irradiation in carcinoma of the vagina: Long-term evaluation of results
43. Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: Analysis of two different methods
44. Radiation therapy in management of carcinoma of the vulva with emphasis on conservation therapy
45. The effect of topical estrogen on irradiated vaginal epithelium
46. Ovarian function in patients receiving adjuvant chemotherapy for breast cancer
47. The female genital tract
48. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva
49. Long-term follow-up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease
50. Psychosexual functioning after treatment for gynecological cancer An integrative model review of determinant factors and clinical guidelines
51. Disorders of the endocrine system due to radiation and cytotoxic chemotherapy
52. Effects of cancer chemotherapy on gonadal function of patients
53. Sexuality for patients with gynecologic cancer
54. Sexual function after surgical and radiation therapy for cervical carcinoma
55. Amenorrhea in patients with Hodgkin's disease treated with antineoplastic agents
56. Oral complications in patients receiving treatment for malignancies other than of the head and neck
57. Concurrent radiation and chemotherapy in vulvar carcinoma
58. Some maritalsexual concomitants of carcinoma of the cervix
59. Cyclophosphamide-induced ovarian failure